For instance, miR-141 and CEA are well-established biomarkers in colorectal cancer (CRC), where studies have demonstrated that their combined use enhances sensitivity compared to individual markers alone, thereby reducing the misdiagnosis rate among CRC patients. Here, CEACAM5 is linked to colorectal carcinoma.